Kewei Li

1.8k total citations
44 papers, 996 citations indexed

About

Kewei Li is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Kewei Li has authored 44 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Surgery, 19 papers in Pulmonary and Respiratory Medicine and 10 papers in Hepatology. Recurrent topics in Kewei Li's work include Gallbladder and Bile Duct Disorders (15 papers), Pediatric Hepatobiliary Diseases and Treatments (13 papers) and Intestinal Malrotation and Obstruction Disorders (6 papers). Kewei Li is often cited by papers focused on Gallbladder and Bile Duct Disorders (15 papers), Pediatric Hepatobiliary Diseases and Treatments (13 papers) and Intestinal Malrotation and Obstruction Disorders (6 papers). Kewei Li collaborates with scholars based in China, United States and Taiwan. Kewei Li's co-authors include Chuan Wang, Guanlin Liang, Tianfu Wen, Junwen Qu, Chen Li, Chuan Li, Yunhao Tang, Kai Mi, Guiyang Wang and Zhiqing Yuan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Medicine.

In The Last Decade

Kewei Li

40 papers receiving 983 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kewei Li China 16 574 365 191 172 162 44 996
M Mori Japan 14 266 0.5× 197 0.5× 116 0.6× 100 0.6× 141 0.9× 38 939
Haibin Zhang China 13 162 0.3× 185 0.5× 83 0.4× 73 0.4× 121 0.7× 66 646
Seung‐Bum Ryoo South Korea 17 358 0.6× 73 0.2× 93 0.5× 221 1.3× 111 0.7× 76 753
Keigo Ozono Japan 7 484 0.8× 283 0.8× 193 1.0× 309 1.8× 130 0.8× 18 945
Federica Pedica Italy 17 375 0.7× 230 0.6× 248 1.3× 379 2.2× 136 0.8× 55 933
Gregory Kouraklis Greece 17 228 0.4× 142 0.4× 182 1.0× 191 1.1× 210 1.3× 43 822
Pauline Kane United Kingdom 14 356 0.6× 86 0.2× 141 0.7× 118 0.7× 43 0.3× 36 720
Kiyonori Furukawa Japan 16 312 0.5× 127 0.3× 91 0.5× 240 1.4× 182 1.1× 61 762
Yuichi Kojima Japan 18 552 1.0× 322 0.9× 117 0.6× 84 0.5× 190 1.2× 102 1.1k

Countries citing papers authored by Kewei Li

Since Specialization
Citations

This map shows the geographic impact of Kewei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kewei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kewei Li more than expected).

Fields of papers citing papers by Kewei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kewei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kewei Li. The network helps show where Kewei Li may publish in the future.

Co-authorship network of co-authors of Kewei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Kewei Li. A scholar is included among the top collaborators of Kewei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kewei Li. Kewei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Xiang, Kewei Li, Yan Huang, et al.. (2025). Fe-curcumin nanozymes-mediated reactive oxygen species scavenging and anti-apoptotic effects on age-related cataracts. Materials Today Bio. 32. 101850–101850. 2 indexed citations
3.
Xu, Dong, Kewei Li, Lin Song, et al.. (2023). Multi-view progression diagnosis of thyroid cancer by integrating platelet transcriptomes and blood routine tests. Computers in Biology and Medicine. 167. 107613–107613.
4.
Li, Kewei, Zhong Liu, Peipei Wu, et al.. (2023). Micro electrical fields induced MSC-sEVs attenuate neuronal cell apoptosis by activating autophagy via lncRNA MALAT1/miR-22-3p/SIRT1/AMPK axis in spinal cord injury. Journal of Nanobiotechnology. 21(1). 451–451. 23 indexed citations
6.
Liu, Tianyu, Xiaolin Hu, Kewei Li, et al.. (2022). Case report: An ectopic adrenocortical adenoma in the renal sinus. Frontiers in Oncology. 12. 934862–934862. 2 indexed citations
7.
Li, Kewei, et al.. (2022). Re-Endothelialization of Decellularized Liver Scaffolds: A Step for Bioengineered Liver Transplantation. Frontiers in Bioengineering and Biotechnology. 10. 833163–833163. 15 indexed citations
8.
Yuan, Zhiqing, Yingbin Liu, Xuxu Sun, et al.. (2021). A redox probe screens MTHFD1 as a determinant of gemcitabine chemoresistance in cholangiocarcinoma. Cell Death Discovery. 7(1). 89–89. 5 indexed citations
9.
Xie, Xiaolong, Yang Wu, Kewei Li, et al.. (2021). Preliminary Experiences With Robot-Assisted Choledochal Cyst Excision Using the Da Vinci Surgical System in Children Below the Age of One. Frontiers in Pediatrics. 9. 741098–741098. 17 indexed citations
10.
Liu, Jiaye, et al.. (2021). Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Children and Adolescents: Systematic Review and Meta-Analysis. International Journal of Public Health. 66. 1604371–1604371. 49 indexed citations
11.
Xie, Xiaolong, et al.. (2020). Learning curve of robot-assisted choledochal cyst excision in pediatrics: report of 60 cases. Surgical Endoscopy. 35(6). 2690–2697. 19 indexed citations
12.
Xie, Xiaolong, Yujun Li, Kewei Li, Qi Wang, & Bo Xiang. (2020). Total robot-assisted choledochal cyst excision using da Vinci surgical system in pediatrics: Report of 10 cases. Journal of Pediatric Surgery. 56(3). 553–558. 14 indexed citations
13.
Wang, Xiaopeng, et al.. (2020). Calcipotriol Inhibits NLRP3 Signal Through YAP1 Activation to Alleviate Cholestatic Liver Injury and Fibrosis. Frontiers in Pharmacology. 11. 200–200. 38 indexed citations
14.
Qu, Junwen, et al.. (2019). Feasibility and safety of single-incision laparoscopic cholecystectomy versus conventional laparoscopic cholecystectomy in an ambulatory setting. Hepatobiliary & pancreatic diseases international. 18(3). 273–277. 16 indexed citations
15.
Qu, Junwen, Zhiqing Yuan, Guiyang Wang, Xiaopeng Wang, & Kewei Li. (2019). The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice. International Immunopharmacology. 70. 147–155. 80 indexed citations
17.
Yuan, Zhiqing, Guiyang Wang, Junwen Qu, Xiaopeng Wang, & Kewei Li. (2018). 9-cis-retinoic acid elevates MRP3 expression by inhibiting sumoylation of RXRα to alleviate cholestatic liver injury. Biochemical and Biophysical Research Communications. 503(1). 188–194. 10 indexed citations
18.
He, Min, et al.. (2016). Diagnosis and Therapy of Ectopic Hepatocellular Carcinoma Growing in the Intrahepatic Bile Duct.. PubMed. 26(11). 130–132. 3 indexed citations
19.
Zhu, Hongyi, Ming Xu, Huojian Shen, et al.. (2015). A meta-analysis of single-stage versus two-stage management for concomitant gallstones and common bile duct stones. Clinics and Research in Hepatology and Gastroenterology. 39(5). 584–593. 76 indexed citations
20.
Li, Kewei. (2010). Hepatic mucormycosis mimicking hilar cholangiocarcinoma: A case report and literature review. World Journal of Gastroenterology. 16(8). 1039–1039. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026